Blog Categories: Research

  • Pink Ribbons Won't Get the Job Done

    National Breast Cancer Coalition president Fran Visco appears in The Daily Beast to talk about advocacy, research and why we need a different approach to end breast cancer.  As usual, she's right.

    Filed Under:
  • NCI Meeting Challenges of Open Source Data Project

    An interesting article about work proceeding to develop open source collaboration for cancer research information.  NCI currently has a Cancer Genome Atlas, which is part of their CancerBiomedical Informatics Grid.  Both seek to be important open platforms or libraries to share information among cancer researchers, and collaborate on research projects, with the key word being "open".  Researchers and cancer activists alike feel the more  cancer data that is available to the research community, the quicker they'll be able to orga

    Filed Under:
  • Northern Ohio Legislators Co-Sponsor "Accelerate the End of Breast Cancer Act"

    Our most sincere thanks to Rep. Steve La Tourette and Rep. Marcy Kaptur for their support of H.R. 3067, the Accelerating the End of Breast Cancer Act 2011.

    H. R. 3067 directs the President to create a special Commission to identify opportunities and ideas within both government and the private sector and recommend projects towards the following goals:

    1. the primary prevention of breast cancer and;

    2. the causes and prevention of breast cancer metastasis

    Commission members will be appointed by the President, the Speaker of the House and the Senate Majority Leader and will seek to develop a strategic vision to meet these goals by January 2020.

    If you live in Rep. Kaptur or Rep. LaTourette's district, please give them a call or send an email thanking them for their co-sponsorship of H.R. 3067.

    If your representative hasn't signed on as a cosponsor yet, please give them a call today and ask them to do so.

    For more information about the Act and National Breast Cancer Coalition's other initiatives for Breast Cancer Deadline 2020,  please visit their web site.

    Filed Under:
  • Update: DoD Breast Cancer Research Deadline & Rep. Marcia Fudge Signs On

    National Breast Cancer Coalition's latest email message advises the deadline for Representatives to sign the "Dear Colleague" letter for renewed 2013 funding of the DoD Breast Cancer Research Program has been extended to Monday, March 19So please call your members today!

    Rep. Marcia Fudge is the first Ohio member of Congress to sign the "Dear Colleague" letter!  Congratulations, Rep. Fudge and thanks for your support. 

    Filed Under:
  • Help Renew $120 Million for Breast Cancer Research in 2013 !

     

    URGENT!!!!  Deadline Friday, March 16!  National Breast Cancer Coalition is urging breast cancer activists to contact their members of Congress to ask them to sign onto the Dear Colleague Letter in support of renewed funding for the DoD Breast Cancer Research Program.

    Filed Under:
  • Scientists Discover Protein Key to Breast Cancer Metastasis

    Researchers at Weill Cornell Medical College have discovered more about how breast cancer cells transform themselves in order to metastasize to other organs and "seed" new tumors, according to Science Daily

    Filed Under:
  • Accelerating the End of Breast Cancer - Sign the Petition!

    National Breast Cancer Coalition, through it's Breast Cancer Deadline 2020 project, recently developed a plan to end breast cancer. NBCC believes that, by focusing research efforts on the following key areas, we will have the keys to eradicating the disease.

    1. Developing a vaccine to prevent breast cancer and,

    2. Focusing research on answering the question of what causes breast cancer to metastasize

    Filed Under:
  • Changing the Conversation About Breast Cancer

    Following is a "Letter to the Editor" from the National Breast Cancer Coalition that NOBCCF will be sending to newspapers in our area. If you would like information about how to have this letter appear in your local newspaper, please give us a call at 440-717-9912.

    Filed Under:
  • Attending San Antonio Breast Cancer Symposium

    Thanks to a scholarship from the Alamo Breast Cancer Foundation, I'll be attending the San Antonio Breast Cancer Symposium in December of this year. I've attended three times previously, and can't emphasize enough how important this program is. One of the first breast cancer research symposiums to adopt a program for inclusion of consumer advocates, it provides a vital opportunity for breast cancer survivors to participate in shaping the direction of future research and treatment.

    As always, I'll keep everyone posted about the Symposium activities via this blog and Twitter. Stay tuned.

    Filed Under:
  • National Center to Advance Translational Science

    National Breast Cancer Coalition provides an excellent summary of the NIH's new National Center to Advance Translational Science.

    This new approach to coordinating basic research into focused development of targets and treatments could advance treatments much more quickly.

    While you're visiting NBCC's web site, don't forget to download a free copy of their 2011 Progress Report on the Breast Cancer Deadline 2020.  It's packed with quality information - so much that you never knew about the status of breast cancer research.

    Filed Under:
  • Vitamin D Levels Linked to Aggressive Breast Tumors

    A recent study conducted by the University of Rochester Medical Center showed a strong link between Vitamin D deficiency and breast cancer progression. The close correlation between low Vitamin D levels and tumor progression is strong enough to recommend oncologists monitor the levels in patients as they undergo treatment.

    Read more

    http://www.urmc.rochester.edu/news/story/index.cfm?id=3182

    Filed Under:
  • Hormone replacement therapy increased deaths in WHI study: National Breast Cancer Coalition

    New data from the Women's Health Initiative Study on post-menopausal hormone replacement therapy shows HRT not only increases breast cancer incidence in post-menopausal women, it also increases the rate of aggressive forms of breast cancer as well as increased deaths. It's more evidence that women should avoid hormone replacement therapy to treat symptoms of menopause. Read more below:

    Filed Under: